Bausch & Lomb updates vitamin based on AREDS 2 data

Bausch & Lomb has removed Omega 3 fatty acids from its PreserVision Eye Vitamin AREDS2 Formula based on the latest clinical evidence from the National Eye Institute’s study. The new formula began shipping to U.S. wholesalers in July and should be available at retailers soon.

Introduced in 2010, the original supplement included lutein, zeaxanthin and 1,000 mg of omega-3 fatty acids, reflecting the potential benefit of these nutrients that also formed the rationale for the AREDS 2 protocol. When the AREDS 2 findings were published earlier this year, Bausch & Lomb announced it would reformulate the supplement to match the updated recommendation.

The daily dose (two soft gels) of the new formula provides the exact same levels of all six clinically proven nutrients as the NEI-supported formula: vitamin C (500mg), vitamin E (400 IU), lutein (10mg)/zeaxanthin (2mg), zinc (80mg zinc oxide), and copper (2mg cupric oxide). The combination of these nutrients at the specific levels recommend by the NEI is only available from Bausch & Lomb.